Published • loading... • Updated
FDA approves first-of-its-kind robotic device designed to automatically draw blood from patients
Clinical testing showed Aletta performed blood draws at rates comparable to or better than trained human phlebotomists, the FDA said.
- The Food and Drug Administration authorized Aletta, a standalone robotic device designed to automate blood draws in outpatient settings without hands-on operator intervention.
- Michelle Tarver, director of the FDA Center for Devices and Radiological Health, stated that "blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists."
- Aletta uses near-infrared light and Doppler ultrasound to identify suitable veins, while one phlebotomist can supervise up to three devices simultaneously during each blood-draw session.
- Clinical testing showed Aletta achieved successful blood-draw rates comparable to or better than trained phlebotomists; the device incorporates safety measures including automatic needle detachment if excessive patient movement occurs.
- Although Aletta has received federal authorization, no official timeline exists for when providers will begin implementing the robotic device in doctors' offices across the United States.
Insights by Ground AI
17 Articles
17 Articles
FDA approves robot that can find your vein, insert a needle, and draw blood without human help
Called Aletta, the robot begins the process by instructing the adult patient on how to position their arm. Once in the correct place, the patient or a supervisor presses a button to begin.Read Entire Article
Robotic Phlebotomist Stand-In Gets FDA's Blessing
(MedPage Today) -- The FDA authorized the first robotic device that can independently draw patients' blood without a hands-on operator, the agency announced on Wednesday. The Aletta device uses near-infrared light and Doppler ultrasound to locate...
·New York, United States
Read Full Article
Technologue.id, Jakarta – The United States Food and Drug Administration (FDA) has approved a new robotic device called Aletta, designed to automate the blood draw process for outpatients. Aletta is
Coverage Details
Total News Sources17
Leaning Left2Leaning Right0Center12Last UpdatedBias Distribution86% Center
Bias Distribution
- 86% of the sources are Center
86% Center
14%
C 86%
Factuality
To view factuality data please Upgrade to Premium
